Summary
Overview
Work history
Education
Skills
Additional Information
Certification
Publication
Timeline
Generic

Nasser Alaqel

Buraydah, Qassim,Saudi Arabia

Summary

Medical director at Prince Faisal Cancer Center, Buraydah.Qassim, Saudi Arabia.

Medical Oncology Consultant at PFCC.

Overview

21
21
years of professional experience
1
1
Certification

Work history

Medical Director

Prince Faisal Cancer Center
Buraydah, Saudi Arabia
02.2024 - Current

Medical Oncology Consultant

Princs Faisal Cancer Center
Buraydah, Qassim
02.2023 - Current

Medical Oncology Consultant

Security Forces Hospital
Riyadh, Saudi Arabia
01.2020 - 01.2023

Medical Oncology consultant

King Salman Specialist Hospital
Hail, Saudi Arabia
05.2019 - 12.2019

Medical Oncology Fellow then Associate Consultant

King Abdullah Medical City
Makkah, Saudi Arabia
01.2015 - 02.2019

Internal Medicine Resident

King Abdul Aziz Hospital
Taif, Saudi Arabia
10.2013 - 12.2014

Senior Resident (R3-R4)

Internal Medicine Resident

King Fahad Hospital
Albaha, Saudi Arabia
12.2009 - 09.2011
  • Junior Resident (R1-R2)

Internal Medicine Physician

Althager Hospital
Jeddah, Saudi Arabia
01.2005 - 01.2009

Education

Bachelor of Medicine,Bachelor of Surgery -

Aden University
Aden, Yamen
04.2001 -

Skills

  • Team Player
  • Motivated
  • Patient Advocate
  • Enthusiastic
  • Work under pressure
  • Flexible

Additional Information

Language : Arabic , English

Marital Status: Married

Certification

  • Saudi Board in Internal Medicine 10-2009 till 12-2013
  • Saudi Fellowship in Medical Oncology 01-2015 till 12-2016
  • BLS
  • ACLS
  • FCCS


Publication


- A disease registry study to observe treatment effect in HER2 positive unresectable or metastatic breast cancer. article  july 2017


 - observational study for treatment response in high grade glioma with MGMT negative tumor. august 2018.


- Efficacy and prognostic significance of triflurodine/tipiracil beyond oxaliplatin and irinotecan based chemotherapy in patients with refractory metastatic colorectal cancer: An observational multicenter study: ASCO Abstract 2021 .


- Efiicacy and tolerability of Cetuximab 750mg/m2 every 3 weeks in metastatic colorectal cancer, articl jun 2023.


- Prospective validation study of COMPASS-CAT model for symptomatic venous thromboembolism risk in cancer patients. april 2024.





Timeline

Medical Director

Prince Faisal Cancer Center
02.2024 - Current

Medical Oncology Consultant

Princs Faisal Cancer Center
02.2023 - Current

Medical Oncology Consultant

Security Forces Hospital
01.2020 - 01.2023

Medical Oncology consultant

King Salman Specialist Hospital
05.2019 - 12.2019

Medical Oncology Fellow then Associate Consultant

King Abdullah Medical City
01.2015 - 02.2019

Internal Medicine Resident

King Abdul Aziz Hospital
10.2013 - 12.2014

Internal Medicine Resident

King Fahad Hospital
12.2009 - 09.2011

Internal Medicine Physician

Althager Hospital
01.2005 - 01.2009

Bachelor of Medicine,Bachelor of Surgery -

Aden University
04.2001 -
Nasser Alaqel